Actinium Pharmaceuticals Inc (ATNM)

1.45
AMEX : Health Care
Prev Close 1.45
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.86 / 2.22
Avg Volume 824.90K
Exchange AMEX
Shares Outstanding 55.81M
Market Cap 78.69M
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Actinium Pharmaceuticals Announces Active Presence At The BMT Tandem Meetings

Actinium Pharmaceuticals Announces Active Presence At The BMT Tandem Meetings

BMT Tandem Meetings are the largest gathering of experts in the field of bone marrow transplant and are expected to provide further exposure for Iomab-B and the SIERRA trial

Actinium Pharmaceuticals To Present At Source Capital Group's 2017 Disruptive Growth & Healthcare Conference

Actinium Pharmaceuticals To Present At Source Capital Group's 2017 Disruptive Growth & Healthcare Conference

- Actinium presentation scheduled for Thursday, February 16, 2017 at 9:00 AM ET -

These 5 Stocks Under $10 Could Explode Up Soon

These 5 Stocks Under $10 Could Explode Up Soon

Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.

Actinium Pharmaceuticals To Present At BIO CEO & Investor Conference

Actinium Pharmaceuticals To Present At BIO CEO & Investor Conference

Actinium presentation scheduled for Monday, February 13, 2017 at 10 AM ET

Actinium Pharmaceuticals To Present At 9th Annual Biotech Showcase™ 2017 Conference 

Actinium Pharmaceuticals To Present At 9th Annual Biotech Showcase™ 2017 Conference 

Actinium to present at 2 PM PST on Tuesday, January 10th

Actinium Pharmaceuticals To Present At 9th Annual Biotech Showcase™ 2017 Conference

Actinium Pharmaceuticals To Present At 9th Annual Biotech Showcase™ 2017 Conference

Actinium to present at 2 PM PST on Tuesday, January 10th

Actinium Further Strengthens Clinical Development Team With Senior Hire To Support Later-Stage Clinical Trials

Actinium Further Strengthens Clinical Development Team With Senior Hire To Support Later-Stage Clinical Trials

Director of Clinical Operations brings nearly two decades of clinical development and pharmaceutical industry experience to Actinium

Actinium Pharmaceuticals To Present At LD Micro Main Event Investor Conference

Actinium Pharmaceuticals To Present At LD Micro Main Event Investor Conference

Presentation scheduled for Tuesday, December 6, 2016 at 11:30 AM PST and management will be available to meet with investors

Actinium Announces Acceptance Of Actimab-A Data For Poster Presentation At American Society Of Hematology Annual Meeting

Actinium Announces Acceptance Of Actimab-A Data For Poster Presentation At American Society Of Hematology Annual Meeting

Data from Phase 1/2 trial to be presented at 58th Annual Meeting

Actinium Announces Closing Of Public Offering Of Common Stock

Actinium Announces Closing Of Public Offering Of Common Stock

Actinium raised total gross proceeds of $10 million